Document is current
Any future updates will be listed below
-
Authors
Wheeler, Stephanie B. https://orcid.org/0000-0002-3399-9047
Biddell, Caitlin B.
Manning, Michelle L.
Gellin, Mindy S.
Padilla, Neda R.
Spees, Lisa P.
Rogers, Cynthia D.
Rodriguez-O’Donnell, Julia
Samuel-Ryals, Cleo
Birken, Sarah A.
Reeder-Hayes, Katherine E.
Petermann, Victoria M.
Deal, Allison M.
Rosenstein, Donald L.
-
Funding
Funding for this research was provided by:
National Cancer Institute (1-R01-CA240092-02, 3-P30-CA016086-44-S4, T32-CA-116339, T32CA057726-27)
- License Information
-
More Information
Article History
Received: 18 February 2022
Accepted: 13 September 2022
First Online: 3 October 2022
Declarations
:
: This study was approved by the UNC Chapel Hill Institutional Review Board (IRB-20-1997, IRB-20-3181, IRB-19-3156). Written or verbal informed consent to participate will be obtained from all participants.
: Not applicable
: SBW, DLR, KRH, CSR, MM, MG, and NP have received funding paid to their institution from the Pfizer Foundation. LPS and SBW have received funding paid to their institution from AstraZeneca.
